The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Overcoming cellular barriers for RNA therapeutics
Abstract
RNA-based therapeutics, such as small-interfering (siRNAs), microRNAs (miRNAs), antisense oligonucleotides (ASOs), aptamers, synthetic mRNAs and CRISPR-Cas9, have great potential to target a large part of the currently undruggable genes and gene products and to generate entirely new therapeutic paradigms in disease, ranging from cancer to pandemic influenza to Alzheimer's disease. However, for these RNA modalities to reach their full potential, they first need to overcome a billion years of evolutionary defenses that have kept RNAs on the outside of cells from invading the inside of cells. Overcoming the lipid bilayer to deliver RNA into cells has remained the major problem to solve for widespread development of RNA therapeutics, but recent chemistry advances have begun to penetrate this evolutionary armor.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As an emerging programmable gene interference technique, siRNA offers high specificity and flexibility in targeting the diseased human genome [236].”
From Emerging role of exosomes in cancer therapy: progress and challenges (2025) · cites this paper as [236]
In the citing paper
“Many obstacles still exist despite the rise in studies on delivery platforms, including toxicity and the precise distribution of mRNA to extrahepatic organs [13, 14].”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [13]
In the citing paper
“Independent of the administration route, several evolutionary barriers are designed to prevent any intrusion of foreign nucleic acids and thus limit the delivery of exogenous mRNA [74].”
From Three decades of messenger RNA vaccine development (2019) · cites this paper as [74]
In the citing paper
“For instance, RNA interference (RNAi) technology enables the downregulation of disease related genes and protein expression; mRNA mediates the expression and supplementation of therapeutic proteins; the CRISPR gene editing system facilitates gene engineering in vivo or through cell engineering ex vivo.[6, 9, 11, 17–20]”
From RNA delivery biomaterials for the treatment of genetic and rare diseases (2019) · cites this paper as [19]
In the citing paper
“For instance, RNA interference (RNAi) technology enables the downregulation of disease related genes and protein expression; mRNA mediates the expression and supplementation of therapeutic proteins; the CRISPR gene editing system facilitates gene engineering in vivo or through cell engineering ex vivo.[6, 9, 11, 17–20]”
From RNA delivery biomaterials for the treatment of genetic and rare diseases (2019) · cites this paper as [19]
In the citing paper
“For instance, RNA interference (RNAi) technology enables the downregulation of disease related genes and protein expression; mRNA mediates the expression and supplementation of therapeutic proteins; the CRISPR gene editing system facilitates gene engineering in vivo or through cell engineering ex vivo.[6, 9, 11, 17–20]”
From RNA delivery biomaterials for the treatment of genetic and rare diseases (2019) · cites this paper as [19]
In the citing paper
“With the development of chemical modifications on RNA molecules, modified siRNA are reported to remain intact for long durations under circulation, which provides the possibility of delivering siRNA without the shielding of nanoparticles.[19, 75, 76]”
From RNA delivery biomaterials for the treatment of genetic and rare diseases (2019) · cites this paper as [19]
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Direct Gene Transfer into Mouse Muscle in Vivo
Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A., & Felgner, P. L. (1990) · Science · doi:10.1126/science.1690918 · Cited by 4,173
Doherty, G. J., & McMahon, H. T. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.081307.110540 · Cited by 3,075
In vivo genome editing using Staphylococcus aureus Cas9
Ran, F. A., Cong, L., Yan, W. X., Scott, D. A., Gootenberg, J. S., Kriz, A. J., Zetsche, B., Shalem, O., Wu, X., Makarova, K. S., et al. (2015) · Nature · doi:10.1038/nature14299 · Cited by 2,687
Flagged first, then by citations
Research works printed but not linked: 2
- Rich, A. in Horizons In Biochemistry (eds. Kasha, M. & Pullman, B.) 103–126 (Academic Press, New York, 1962).
- Cummings, R. & McEver, R. in Essentials of Glycobiology. 2nd edn. (eds. Varki, A. et al.) Chapter 31 (Cold Spring Harbor (NY); Cold Spring Harbor Laboratory Press, 2009).
Cited by
Sorted by citations
Items 801–900 of 1,000
Choe, J. Y., Son, D. S., Kim, Y., Lee, J., Shin, H., Kim, W. J., Kang, Y. G., Dua, P., Hong, S. W., Park, J. H., et al. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00942 · Cited by 6
Liu, Y., Gu, Y., Fu, Z., Xu, Y., Wu, X., & Chen, J. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c01350 · Cited by 6
MicroRNAs: From Junk RNA to Life Regulators and Their Role in Cardiovascular Disease
Amodio, F., Caiazza, M., Fimiani, F., Calabrò, P., & Limongelli, G. (2021) · Cardiogenetics · doi:10.3390/cardiogenetics11040023 · Cited by 6
LncRNA Functional Screening in Organismal Development
Li, Y., Zhai, H., Tong, L., Wang, C., Xie, Z., & Zheng, K. (2023) · Non-Coding RNA · doi:10.3390/ncrna9040036 · Cited by 6
Borsa, B. A., Hernandez, L. I., Jiménez, T., Tellapragada, C., Giske, C. G., & Hernández, F. J. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.07.057 · Cited by 8
Simple Scattering: Lipid nanoparticle structural data repository
Kim, L. J., Shin, D. S., Leite, W. C., O’Neill, H., Ruebel, O., Tritt, A., & Hura, G. L. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1321364 · Cited by 5
Cell-Penetrating Peptides Targeting Mitochondria
Cerrato, C. P., & Langel, Ü. (2018) · Springer eBooks · doi:10.1007/978-3-319-73344-9_26 · Cited by 6
Winkler, J. (2018) · Nucleic Acid Therapeutics · doi:10.1089/nat.2017.0713 · Cited by 7
Preparation and Characterization of a Liver Targeted, Poly(amidoamine) Based, Gene Delivery System
Ebeid, K., Geary, S. M., & Salem, A. K. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2128-8_24 · Cited by 6
Wang, S., Li, Y., Wang, Y., & Feng, M. H. (2007) · PubMed · Cited by 6
Hawthorne, G., Harbach, S. L., & Wilson, A. (2018) · Bioanalysis · doi:10.4155/bio-2017-0279 · Cited by 6
Laturski, A. E., Dulay, M. T., Perry, J. L., & DeSimone, J. M. (2025) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5c00028 · Cited by 6
Breaking through barrier: The emerging role of nucleic acids-based drug delivery in stroke
Yin, G., Zheng, Y., Li, M., Wu, G., & Luo, Y. (2025) · Progress in Materials Science · doi:10.1016/j.pmatsci.2025.101436 · Cited by 5
An Introduction to Cell Signalling Pathways and Their Dysregulation in Cancer
Talath, S., Wali, A. F., El‐Tanani, M., Al-Dhaheri, Y., Jain, P., & Mottershead, R. (2025) · Springer eBooks · doi:10.1007/978-981-96-2763-9_1 · Cited by 6
Applications of Advanced ASOs, RNA Mimics, and Others in RNA-Based Therapeutics
Chakkyarath, V. (2025) · Springer eBooks · doi:10.1007/978-981-96-3456-9_3 · Cited by 5
Liang, Y., Tan, X., Yang, Y. R., Zhang, J., Gao, X., Yin, M., Gao, H., Yang, S. X., & Zhang, K. (2025) · Nano Research · doi:10.26599/nr.2025.94907874 · Cited by 6
Ma, P., Ma, H., Li, J., Bi, W., Zhang, S., Hou, W., & Xu, H. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104532 · Cited by 6
RNA-based drugs: current, imminent and possible therapeutic applications
Torrisi, S. A., Geraci, F., Diolosà, L., Luca, A. D., Falzone, L., Drago, F., Libra, M., & Leggio, G. M. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108958 · Cited by 8
Grau, M., Martini, N., Thalmayr, S., Höhn, M., Merkel, O. M., Winkeljann, B., & Wagner, E. (2026) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2026.139973 · Cited by 5
Advances in Nanocarriers for Delivering Therapeutic Agents Against Hepatitis B Virus
Li, J., Yuan, J., Li, H., Guo, J., Li, M., Zhang, T., Liang, X., Fan, H., & Liu, X. (2024) · Advanced NanoBiomed Research · doi:10.1002/anbr.202300132 · Cited by 5
Beyond the membrane: Exploring non-viral methods for mitochondrial gene delivery
Singh, D. (2024) · Mitochondrion · doi:10.1016/j.mito.2024.101922 · Cited by 5
RNA-based therapies in hepatocellular carcinoma: state of the art and clinical perspectives
Xing, L., Wang, Z., Li, D., Li, J., & Liu, M. (2024) · Hepatoma Research · doi:10.20517/2394-5079.2024.25 · Cited by 6
Promising RNA-based therapies for viral infections, genetic disorders, and cancer
Musa, D. A., Raji, M. O., Sikiru, A. B., Aremu, H. K., & Aigboeghian, E. A. (2024) · Academia molecular biology and genomics. · doi:10.20935/acadmolbiogen7329 · Cited by 7
Yin, C., Deng, M., Yu, J., Chen, Y., Zheng, K., Huang, Y. F., Deng, X., Tian, Y. E., Ma, Y., Zeng, B., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-75997-8 · Cited by 5
Saha, S., Tandon, R., Sanku, J., Kumari, A., Shukla, R., & Srivastava, N. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125463 · Cited by 6
Tan, J., Xu, Q., Pandupuspitasari, N. S., Khan, F. A., Wu, D., Sun, F., & Huang, C. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117286 · Cited by 5
Stereo-random oligonucleotides enable efficient recruitment of ADAR in vitro and in vivo
Pfeiffer, L. S., Merkle, T., Vogel, P., Jarmoskaite, I., Geisinger, J. M., Latifi, N., Herrera‐Barrera, M., Zhang, F., Groß, L., Schlitz, C., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-64434-7 · Cited by 7
Synthetic Polymer Tag for Intracellular Delivery of siRNA
Tai, W., & Gao, X. (2018) · Advanced Biosystems · doi:10.1002/adbi.201800075 · Cited by 5
The effects of miR-375 expression in NSCLC via the 14-3-3ζ/ERK/MYC pathway
Meng, H., Wu, J., Huang, Q., Ren, J., Huang, J., Yuan, W., He, X., Wang, Y., Cui, C., Xu, S., et al. (2018) · Oncology and Translational Medicine · doi:10.1007/s10330-018-0290-0 · Cited by 5
Cytoplasmic delivery of small interfering RNA by photoresponsive non-cationic liposomes
Somiya, M., Sakaeda, K., Ishii, Y., & Kuroda, S. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102488 · Cited by 5
Pinpoint modification strategy for stabilization of single guide RNA
Takeuchi, S., Yamamoto, M., Matsumoto, S., Kenjo, E., Karashima, M., & Ikeda, Y. (2022) · Journal of Chromatography B · doi:10.1016/j.jchromb.2022.123149 · Cited by 5
Emerging Therapeutics and Delivery
Dash, A. K., Medi, B. M., Sarrami, B., Hasanzad, M., Singh, S., & Shukla, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99796-6.00003-5 · Cited by 5
Takatsu, M., Morihiro, K., Watanabe, H., Yuki, M., Hattori, T., Noi, K., Aikawa, K., Noguchi, K., Yohda, M., Okazoe, T., et al. (2023) · ACS Chemical Biology · doi:10.1021/acschembio.3c00612 · Cited by 5
Nie, D., Lv, Y., Gao, D., Xu, A., Li, Q., Li, J., Lü, X., Wang, B., Wang, J., Liu, C., et al. (2024) · Nano Today · doi:10.1016/j.nantod.2024.102480 · Cited by 5
Development and Advantages of Drug Delivery Systems
Zhang, Y., Liu, X., & Li, X. (2025) · Springer eBooks · doi:10.1007/978-981-19-8930-8_2 · Cited by 5
Development of Bioreduction Labile Protecting Groups for the 2′-Hydroxyl Group of RNA
Saneyoshi, H., Nakamura, K., Terasawa, K., & Ono, A. M. (2020) · Organic Letters · doi:10.1021/acs.orglett.0c02086 · Cited by 5
Victorio, C. B. L., Novera, W., Tham, J. Y., Watanabe, S., Vasudevan, S. G., & Chacko, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239260 · Cited by 5
Paramasivam, P., Stöter, M., Corradi, E., Costa, I. D., Höijer, A., Bartesaghi, S., Sabirsh, A., Lindfors, L., Arteta, M. Y., Nordberg, P., et al. (2021) · RNA · doi:10.1261/rna.078895.121 · Cited by 6
Lipofection mediated transfection fails for sea urchin coelomocytes
Hudgell, M. A. B., & Smith, L. C. (2022) · PLoS ONE · doi:10.1371/journal.pone.0267911 · Cited by 5
A Light‐Triggerable Nanoparticle Library for the Controlled Release of Non‐Coding RNAs
Blersch, J., Francisco, V., Rebelo, C., Jiménez‐Balsa, A., Antunes, H., Gonzato, C., Pinto, S., Simões, S. M. N., Liedl, K. R., Haupt, K., et al. (2019) · Angewandte Chemie · doi:10.1002/ange.201911398 · Cited by 5
Induction of RNAi Responses by Short Left-Handed Hairpin RNAi Triggers
Hagopian, J. C., Hamil, A. S., van den Berg, A., Meade, B. R., Eguchi, A., Palm‐Apergi, C., & Dowdy, S. F. (2017) · Nucleic Acid Therapeutics · doi:10.1089/nat.2017.0686 · Cited by 5
Self-citationC2′-F Stereoconfiguration As a Puckering Switch for Base Stacking at the Dinucleotide Level
Moriou, C., Silva, A. D. D., Prado, M. J. V., Denhez, C., Plashkevych, O., CHATTOPADHYAYA, J. B., Guillaume, D. M., & Clivio, P. (2018) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.7b03186 · Cited by 5
PEGylated gene carriers in serum under shear flow
Yin, D., Wen, H., Wu, G., Li, S., Liu, C., Lu, H., & Liang, D. (2020) · Soft Matter · doi:10.1039/c9sm02397f · Cited by 6
Feichtenschlager, V., Zheng, Y. J., Qu, T., Hohlova, D., Callanan, C., Chen, L.-N., Chen, C., Ho, W. W.-S., Lee, A., Hwang, Y. C., et al. (2025) · Communications Medicine · doi:10.1038/s43856-025-00932-5 · Cited by 6
Trends and Commonalities of Approved and Late Clinical-Phase RNA Therapeutics
Tufeu, M., Herkenne, C., & Kalia, Y. N. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17070903 · Cited by 4
siRNA-mediated therapeutic approaches improve acute kidney injury and limit its worsening
Wang, X., Huang, X., & Yang, B. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1697460 · Cited by 4
Therapeutic oligonucleotides revisited: Focus on siRNA and antisense technologies
Chen, L., Xu, J., Li, J., Liu, G., & Ma, H. (2026) · The Innovation Drug Discovery · doi:10.59717/j.xinn-drugdisc.2026.100007 · Cited by 6
MCT Nanoemulsions for the Efficient Delivery of siRNA
Padilla, M. S., Tangsangasaksri, M., Chang, C., & Mecozzi, S. (2023) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2023.11.013 · Cited by 4
Li, J., & Foged, C. (2024) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2024.2409142 · Cited by 5
Gene Augmentation Techniques to Stimulate Wound Healing Process: Progress and Prospects
Dwivedi, J., Kaushal, S., Jeslin, D., Karpagavalli, L., Kumar, R., Dev, D., & Wal, P. (2024) · Current Gene Therapy · doi:10.2174/0115665232316799241008073042 · Cited by 4
Silvestrini, A. V. P., da Silva, U. J., Fantini, M. C. D. A., & Bentley, M. V. L. B. (2025) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2025.127442 · Cited by 4
Obeng, E., Ergashev, A., Yao, Q., Wu, W., & Chen, G. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s514653 · Cited by 4
Engineered RNA nanostructures for scalable and efficient RNAi-based pesticides
Ying, X., Zhang, T., Ni, X., Zhu, Y., Chen, Q., Bamu, A., Dai, H., & Lin, X. (2025) · Trends in biotechnology · doi:10.1016/j.tibtech.2025.07.027 · Cited by 5
Knowing is not enough; we must apply: the case for rigorous microRNA annotation standards
Hackenberg, M., Kalogeropoulos, P., Peterson, K. J., Friedländer, M. R., & Fromm, B. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf1049 · Cited by 5
Recent advances and clinical prospects of non-viral brain-targeted gene delivery systems
Wang, S., Xu, L.-L., Ma, F., Xu, M., Chen, G., Wang, D., Wu, X., Wang, P., Yu, J., & Shi, L. (2025) · Applied Physics Reviews · doi:10.1063/5.0255745 · Cited by 4
Sarode, A., Ortiz, C., Derstepanian, T., Vargas‐Montoya, N., Patel, P., Khadse, N., Manna, S., Landis, R. F., Skaleski, J., Boeglin, L., et al. (2025) · Advanced Materials · doi:10.1002/adma.202517893 · Cited by 4
mRNA and gene therapy for diabetes: The next-generation treatment frontiers
Mourya, A. K., Jindal, N., & Kumar, A. (2025) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2025.103706 · Cited by 4
Recent advances in factor XII(a) inhibitors: an updated patent landscape (2020-present)
Kalinin, D. V. (2026) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2026.2627911 · Cited by 4
The Versatile Applications of Antisense Oligonucleotides in Modern Medicine
Liang, X., & Zhang, L. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27125612 · Cited by 5
Bai, G., Xue, T., Dong, X., Chinta, U. K., Feng, J., Jin, T., & Wu, F. (2019) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2019.04.008 · Cited by 4
TET2, an “ambiguous” player in inflammation
Espinosa-Oliva, A. M., & Burguillos, M. Á. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.274338 · Cited by 4
Wang, J., Zheng, B. L., Yang, S. J., Jian, F., Sun, H., & Wang, J. (2022) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2022.3240 · Cited by 4
Polymer-Based Transfection Agents Used in CRISPR-CAS9 System
İmamoğlu, R., Kaplan, Ö., Gök, M. K., & Gökçe, İ. (2022) · Türk doğa ve fen dergisi :/Türk doğa ve fen dergisi · doi:10.46810/tdfd.795053 · Cited by 4
Antisense oligonucleotides: a promising therapeutic option against infectious diseases
Tekintaş, Y., & Temel, A. (2023) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2023.2228841 · Cited by 4
Delivery of Rna Drugs: Beyond the Liver, More than Vaccine
Elnaggar, M. G., He, Y., & Yeo, Y. (2023) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2024.114203 · Cited by 4
Farinha, D., Sarmento‐Ribeiro, A. B., & Faneca, H. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s474665 · Cited by 4
Chen, X., Zhang, H., Liu, D., Ma, J., Jin, L., Ma, Y., Li, J., Song, G., & Wang, J. (2025) · Journal of Materials Chemistry B · doi:10.1039/d5tb00117j · Cited by 4
Zhao, H., Zhang, C., Tian, C., Li, L., Wu, B., Qiu, Y., Yu, Y., Stuart, M. A. C., Gao, R., Zhou, X., et al. (2025) · Journal of Materials Chemistry B · doi:10.1039/d5tb00594a · Cited by 4
RNA in the spotlight: the dawn of RNA therapeutics in the treatment of human disease
Stellos, K. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx170 · Cited by 4
Generating aptamers for specific recognition against soft-shelled turtle iridovirus infection
Yu, Q., Liu, M., Li, M., Su, M., Xiao, R., Tong, G., Qin, X., & Li, P. (2021) · Aquaculture · doi:10.1016/j.aquaculture.2021.736348 · Cited by 4
Kang, J.-Y., Cao, X., Wang, F., & Zhao, J. (2022) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2022.116139 · Cited by 4
de Vyver, T. V., Muntean, C., Efimova, I., Krysko, D. V., Backer, L. D., Smedt, S. C. D., & Raemdonck, K. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.10.014 · Cited by 5
Retro-1-Oligonucleotide Conjugates. Synthesis and Biological Evaluation
Agramunt, J., Pedroso, E., Kreda, S. M., Juliano, R. L., & Grandas, A. (2019) · Molecules · doi:10.3390/molecules24030579 · Cited by 4
Production of Recombinant RNA in Escherichia coli Using Eggplant Latent Viroid as a Scaffold
Ortolá, B., & Daròs, J. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1464-8_25 · Cited by 4
Strategies of Polypharmacology
Wang, Z., & Yang, B. (2022) · Springer eBooks · doi:10.1007/978-3-031-04998-9_2 · Cited by 4
Controlling CRISPR-Cas9 Gene Editing
Dowdy, S. F. (2019) · New England Journal of Medicine · doi:10.1056/nejmcibr1906886 · Cited by 4
Self-citationVirus-Mimicking Nanocarriers for The Intracellular Delivery of Therapeutic Biomolecules
Somiya, M., & Kuroda, S. (2020) · Nanomedicine · doi:10.2217/nnm-2020-0078 · Cited by 4
A Historical Overview on mRNA Vaccine Development
Verbeke, R., Cheng, M. H. Y., & Cullis, P. R. (2024) · Wiley eBooks · doi:10.1002/9783527838394.ch1 · Cited by 5
Kwak, M., Hua, T. C., Jin, H., Lee, J. S., & Kim, D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178467 · Cited by 3
Wu, J., Guo, J., Wu, J., Song, J., Xu, J., Lin, Y., Huang, C., Shi, C., Li, J., Li, C., et al. (2025) · Brain · doi:10.1093/brain/awaf330 · Cited by 5
Brown, S., Malinowska, A. L., Bennett, M., Correa-Sánchez, A. F., Valencia, L. L. H., Lucignoli, A. P., Barton, A. K., Clark, L., Sluimer, J. C., Webster, S. P., et al. (2025) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2025.101364 · Cited by 4
Stader, F., Derbalah, A., Żyła, A., Liu, C., Gardner, I. B., & Sepp, A. (2025) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.70108 · Cited by 3
Heendeniya, S. N., Chen, S., Bhatti, S. H., Zahra, Q. U. A., Rahimizadeh, K., Poudel, B. H., Wilton, S. D., & Veedu, R. N. (2025) · Experimental Biology and Medicine · doi:10.3389/ebm.2025.10784 · Cited by 3
Naik, K. A. P., Kethavath, S. N., Rosangzula, K., Saikrishna, J., Sangeetha, R., Patlolla, R. R., Chandgude, A. H., & Banoth, L. (2026) · Springer eBooks · doi:10.1007/978-981-95-5071-5_12 · Cited by 3
LAH5-mediated delivery of prime editor ribonucleoprotein complexes for genome editing
Yao, B., Öktem, M., Yang, G., Wang, Q., Daniels, M. A., Dokter, I., Lefferts, J. W., Gonçalves, M. A. F. V., Doevendans, P. A., van Mil, A., et al. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.126622 · Cited by 3
Phase-separating enzyme-responsive condensates for inhalable delivery of biomacromolecules
Xiao, Y., Zhou, S., Zhu, T., Du, Y., Guo, X., Hu, Q., Wang, L., Deng, S., & Ren, K. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.173695 · Cited by 3
Zhang, Y., Chen, Y., Zhang, Y.-Y., Zhang, Q., Wang, L., Liu, Q.-M., Chen, L.-P., Dong, Q., Wen, Y.-H., He, Z., et al. (2026) · Food Research International · doi:10.1016/j.foodres.2026.118760 · Cited by 2
Modulation of innate immune responses by virus-host interactions in Orthoflavivirus
Upadhyay, A., Walia, P., Kumar, N., Kumar, P., & Tomar, S. (2026) · Virology · doi:10.1016/j.virol.2026.110848 · Cited by 3
Chemical Modification and Delivery System of Small Interfering RNA Drugs★
Li, C., Si, X., Li, J., & Zhang, Y. (2023) · 化学学报 · doi:10.6023/a23040179 · Cited by 4
Lin, Y.-Y., Liao, A., Li, H.-T., Jiang, P.-Y., Lin, Y., Chuang, H., Ma, K., Chen, H.-K., Liu, Y.-T., Shih, C., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137096 · Cited by 3
Cationic Lipid Derived from a Basic Amino Acid: Design and Synthesis
Bravo‐Estupiñan, D. M., Montaño-Samaniego, M., Mora-Rodríguez, R. A., & Ibáñez-Hernández, M. Á. (2024) · Applied Sciences · doi:10.3390/app142310892 · Cited by 3
Jiramitmongkon, K., Rotkrua, P., Khanchaitit, P., Arunpanichlert, J., & Soontornworajit, B. (2025) · PLoS ONE · doi:10.1371/journal.pone.0317559 · Cited by 3
Song, N., Tao, R., Li, H., Zhang, R., Huang, Y. H., Zhang, L., Liu, Y., Yang, D., & Yao, C. (2025) · Angewandte Chemie · doi:10.1002/ange.202500566 · Cited by 3
Kim, T., Yum, K., & Lee, J. B. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.146970 · Cited by 3
Packard, B. Z., Wrightson, J. A., & Komoriya, A. (2020) · Cytometry Part A · doi:10.1002/cyto.a.24174 · Cited by 3
Kim, J., Yun, Y., & Jung, Y. (2022) · Springer eBooks · doi:10.1007/978-3-030-93333-3_1 · Cited by 3
Calling for continuous surgical support in Ukraine
Awuah, W. A., Ng, J. C., David, L., Abdul‐Rahman, T., Sikora, V., & Işık, A. (2023) · International Journal of Surgery · doi:10.1097/js9.0000000000000040 · Cited by 3
Bioresponsive Chimaeric Polymersomes Mediate Sustained and Liver-Specific siRNA Transfection In Vivo
Huang, R., Wang, F., Fu, H., Qi, X., Xing, G., Ren, J., Cheng, L., Meng, F., & Zhong, Z. (2023) · Biomacromolecules · doi:10.1021/acs.biomac.3c00813 · Cited by 3
Chen, P., Yang, W., Mochida, Y., Li, S., Hong, T., Kinoh, H., Kataoka, K., & Cabral, H. (2024) · Angewandte Chemie · doi:10.1002/ange.202317817 · Cited by 3
Intracellular Delivery of Antisense Oligonucleotides by Tri‐Branched Cyclic Disulfide Units
Lyu, F., Hakariya, H., Hiraoka, H., Li, Z., Matsubara, N., Soo, Y., Hashiya, F., Abe, N., Shu, Z., Nakamoto, K., et al. (2024) · ChemMedChem · doi:10.1002/cmdc.202400472 · Cited by 3
Metadata
- Authors
- Dowdy, S. F.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Dowdy, Steven F
- ORCID
- Dowdy, Steven F
- Venue
- Nature Biotechnology
- Published
- 2017-02-27
- Volume
- 35
- Issue
- 3
- Pages
- 222-229
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2594133976
- Cited by
- 1,139
- References
- 105
- Citations by year
- 2026: 103 · 2025: 130 · 2024: 147 · 2023: 133 · 2022: 130 · 2021: 141 · 2020: 104 · 2019: 88 · 2018: 120 · 2017: 41
- FWCI
- 9.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Keywords
- RNA therapeutics, RNA delivery, lipid bilayers, siRNA, microRNA, antisense oligonucleotides, aptamers, synthetic mRNA, CRISPR/Cas9
- MeSH terms
- RNAi Therapeutics, Animals, Cell Membrane, Humans, RNA, RNA Interference, Nanocapsules, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
